We are live on ! Find out more
CCM

Cloverdale Capital Management Portfolio holdings

AUM $135M
1-Year Est. Return 13.89%
This Fund
S&P 500
This Quarter Est. Return
+9.3%
1 Year Est. Return
-13.89%
3 Year Est. Return
+20.77%
5 Year Est. Return
10 Year Est. Return
AUM
$208M
AUM Growth
+$29M
Cap. Flow
+$18.9M
Cap. Flow %
9.08%
Top 10 Hldgs %
71.64%
Holding
35
New
11
Increased
6
Reduced
2
Closed
16

Sector Composition

Rank Sector Weight
1 Industrials 24.86%
2 Consumer Discretionary 19.02%
3 Communication Services 10.69%
4 Technology 9.55%
5 Consumer Staples 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTG icon
26
Heritage Insurance Holdings
HRTG
$889M
-95,644
Closed -$1.45M
LNTH icon
27
Lantheus
LNTH
$6.49B
-318,100
Closed -$5.06M
MDXG icon
28
PUT
MiMedx Group
MDXG
$602M
-185,000
Closed -$1.29M
META icon
29
Meta Platforms (Facebook)
META
$1.42T
-74,500
Closed -$11.9M
META icon
30
PUT
Meta Platforms (Facebook)
META
$1.42T
-10,000
Closed -$1.6M
PRDO icon
31
Perdoceo Education
PRDO
$1.99B
-450,044
Closed -$5.91M
RAMP icon
32
PUT
LiveRamp
RAMP
$2.3B
-44,000
Closed -$999K
NUAN
33
CALL
DELISTED
Nuance Communications, Inc.
NUAN
-381,728
Closed -$5.21M
NUAN
34
DELISTED
Nuance Communications, Inc.
NUAN
-882,851
Closed -$12M
TECD
35
DELISTED
Tech Data Corp
TECD
-180,336
Closed -$15.4M

Similar funds

Cloverdale Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Cloverdale Capital Management held 35 positions worth $208M, up 16% from $179M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Cloverdale Capital Management deployed $18.9M of net new capital in Q2 2018, opening 11 new positions and adding to 6 existing holdings. Its largest new stake was Avanos Medical: 287,499 shares worth $16.5M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Keysight, an estimated $8.13M trimmed.

  • Cloverdale Capital Management's largest Q2 2018 buy was Avanos Medical: 287,499 shares worth $16.5M.
  • Cloverdale Capital Management added most to Woodward in Q2 2018, an estimated $8.08M increase.
  • Cloverdale Capital Management's biggest Q2 2018 reduction was Keysight, cutting an estimated $8.13M.
  • Cloverdale Capital Management fully exited Tech Data Corp in Q2 2018, selling an estimated $15.4M.
  • Cloverdale Capital Management's ten largest holdings make up 72% of its $208M portfolio in Q2 2018.
  • Cloverdale Capital Management opened 11 new positions and closed 16 in Q2 2018.
  • Cloverdale Capital Management's portfolio value rose 16% quarter-over-quarter to $208M.

Based on Cloverdale Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.